Abstract. We develop a novel dual-modal contrast agent-encapsulated-ink poly͑lactic-co-glycolic acid͒ ͑PLGA͒ microbubbles and nanobubbles-for photoacoustic and ultrasound imaging. Soft gelatin phantoms with embedded tumor simulators of encapsulated-ink PLGA microbubbles and nanobubbles in various concentrations are clearly shown in both photoacoustic and ultrasound images. In addition, using photoacoustic imaging, we successfully image the samples positioned below 1.8-cm-thick chicken breast tissues. Potentially, simultaneous photoacoustic and ultrasound imaging enhanced by encapsulated-dye PLGA microbubbles or nanobubbles can be a valuable tool for intraoperative assessment of tumor boundaries and therapeutic margins.
Surgical resection followed by radiation therapy and chemotherapy is the most effective treatment for malignant intracranial tumors. 1, 2 Yet accurate localization of tumors and their boundaries is a critical issue with this method. Intraoperative magnetic resonance imaging ͑MRI͒ is currently the most reliable tool to identify the structural features of tumors. However, MRI alone is not sufficient to delineate diffuse tumor margins, because it cannot identify molecular characteristics at the cellular level. 3, 4 Ultrasound ͑US͒ imaging has been applied as an alternative for tumor resection control, because this imaging modality is relatively inexpensive, portable, and fast enough to provide real-time images. 5 However, due to its low contrast, speckle artifacts, and high operator dependence, the reliability of US imaging is not fully proven. 6 Taking advantage of strong endogenous and exogenous optical contrasts, pure optical imaging has been intraoperatively applied to map tumor margins. 7 However, due to strong light scattering, pure optical imaging suffers from either shallow penetration depth ͑optical microscopy 8 ͒ or poor spatial resolution ͑diffuse optical tomography 9 ͒. Along with the application of new imaging techniques, contrast agents have been intensively investigated to improve the degree of resection and preserve normal tissues. [10] [11] [12] Therefore, there is a pressing need to develop a highly sensitive and high resolution imaging tool with proper contrast agents for monitoring surgical resection of intracranial tumors.
Thanks to its strong optical absorption contrast and high ultrasonic resolution, photoacoustic ͑PA͒ imaging has become a popular technique in tumor imaging in vivo. 13 The principle of this technique is that acoustic waves are generated through thermoelastic expansion when targets absorb a short-pulsed light.
14, 15 The acoustic waves propagate in biological tissues and are detected by ultrasound transducers. The initial pressure rise is proportional to the local optical absorption ͑the product of the local optical absorption coefficient and the local optical fluence͒. The locations of optically absorptive targets can be measured using the arrival times of ultrasound. Since the spatial resolution at depths beyond one optical transport mean free path ͑ Ͼ 1 mm͒ is determined by acoustic parameters, the resolution and imaging depth can be scalable, while pixel numbers, defined as the ratio of the imaging depth to the resolution, are maintained at greater than 100. In addition, a conventional ultrasound system can be easily combined with PA imaging to provide both mechanical contrast ͑morphological information͒ and optical contrast ͑morpho-logical and functional information͒.
In this work, for the first time to our knowledge, we have demonstrated a novel multifunctional contrast agent for PA and US imaging-encapsulated-ink poly͑lactic-coglycolic acid͒ ͑PLGA͒ microbubbles ͑MBs͒ and nanobubbles ͑NBs͒. We successfully imaged gelatin-based encapsulated-ink PLGA MBs and NBs at various concentrations using both PA and US imaging systems. Moreover, deeply positioned ͑ϳ1.8 cm below biological tissues͒ encapsulated-ink PLGA MBs and NBs were clearly imaged using the PA imaging system. These results show that encapsulated-dye PLGA MBs and NBs can potentially be employed to assess intracranial tumor boundaries and therapeutic margins intraoperatively using simultaneous PA and US imaging.
Encapsulated-ink PLGA ͑50:50, RG 502H 12000 Da MW, Boehringer Ingelheim, Germany͒ MBs and NBs were fabricated using a modified double-emulsion process. 16 First, four solutions were prepared: 1. 5 mL of 2.5% w/v PLGA solution of methylene chloride ͑CH 2 Cl 2 , Fisher Scientific, Worcester, Massachusetts͒, 2. 50 mL of 4% w/v polyvinyl alcohol ͑PVA, Fisher Scientific͒ aqueous solution; 3. 0.5 mL of 50% v/v ink ͑Higgins Fountain Pen India nonwaterproof black ink, Sanford, Chicago, Illinois͒ and 4% w/v PVA aqueous solution; and 4. 100 mL of 5% v/v isopropanol aqueous solution. After that, the 0.5-mL aqueous solution of ink and PVA was added to the 5-mL PLGA solution of CH 2 Cl 2 , and emulsified in an ice bath. Then, the emulsion was added drop-wise using a 1000-L pipette to the 50-mL PVA solution in an ice bath and emulsified again. The double emulsion was then added to the isopropanol solution, stirred for 1.5 h by a magnetic stirrer, and then centrifuged. After centrifugation, the supernatant was discarded, and the bubble precipitate was washed by deionized water. The process of centrifugation and washing was repeated three times. The washed spheres were then freeze-dried by a Lyph-lock 4.5 freeze-dry system ͑Labcono Corporation, Kansas City, Missouri͒ for 36 h. Dried bubbles were harvested and stored in a glass bottle at 0°C for further use. For the MBs, the first and second emulsion steps
Eight cylindrical MB and NB tumor simulators, 5 mm in diameter, were fabricated by dispersing MBs and NBs respectively in gelatin solution at four different concentrations ͑2.5, 5, 10, and 15 mg/ mL͒. The gelatin solution ͑concentration: 0.15 g / mL͒ was preheated by a microwave oven and degassed by a vacuum pump in advance. A tissue simulating phantom was fabricated by casting the cylindrical MB and NB tumor simulators in a gelatin pad of 3 ϫ 4 ϫ 0.5 cm.
The tissue simulating phantom was imaged by a 5-MHz linear array US probe ͑Terason, Burlington, Massachusetts͒ and a PA macroscope. The schematic of PA macroscope and the mechanisms of the ring-shaped light illumination are fully described in Ref. 17 . To irradiate the phantoms, we used the wavelength-tunable Ti-sapphire laser ͑LT-2211A, Lotis TII, Minsk, Belarus͒, pumped by a Q-switched Nd:YAG laser ͑LS-2137, Lotis͒ with a pulse duration of 6.5 ns and a pulse repetition rate of 10 Hz. The light fluence on the phantom surface was 3.4 mJ/ cm 2 , within the current ANSI limit. 18 A doughnut-shaped light ͑ = 767 nm͒, formed by concave and conical lenses, traveled through an optical condenser, and was coaxially focused with the ultrasound focal zone in water. The phantoms were positioned under a water tank that had a window with a transparent thin membrane. The PA waves, detected by a single-element 5-MHz ultrasound transducer ͑V308, Panametrics-NDT, Waltham, Massachusetts͒, were first amplified and then transferred to an oscilloscope. The axial and lateral resolutions were 138 and 490 m, respectively. One-dimensional depth-sensitive images along the z axis ͑referred to as A-lines͒ were obtained by measuring the times of arrival of the PA signals. By scanning the samples along the x and y directions, 3-D PA images were formed. 3-D images were projected into 2-D images through maximum amplitude projection ͑MAP͒, which projected the strongest signal along each A-line onto the corresponding x-y plane.
A schematic of encapsulated-ink MBs and NBs is shown in Fig. 1͑a͒ from MBs were stronger than those from NBs. Figure 2͑e͒ shows a linear increase of the US signals as a function of concentration. Note that the US signals in NBs are stronger than those in MBs. The enhanced acoustic contrast by NBs has not been well studied yet, possibly due to particle aggregation and the layering effect. 19, 20 These results strongly support the dual functionality of encapsulated-ink MBs and NBs for PA and US imaging, where the optical contrast stems from ink and the mechanical contrast from bubbles.
To take advantage of the deeper penetration depth of PA imaging with high resolution, we added chicken breast tissues atop the phantom. The phantom was prepared in the same method as mentioned before ͓Fig. 3͑a͔͒. With an 8-mm-thick layer of chicken breast tissue, all eight targets are clearly shown in Fig. 3͑b͒ . With an 18-mm-thick layer, although targets 1, 2, 5, and 6 are relatively dim, targets 3, 4, 7, and 8 are clearly visible in Fig. 3͑c͒ . This result implies that PA imaging is potentially able to delineate deep tumor margins using the encapsulated-ink MBs or NBs.
In summary, we successfully developed and tested encapsulated-ink PLGA MBs and NBs as a dual-modality contrast agent for PA and US imaging. Deeply positioned encapsulated-ink MBs and NBs were clearly imaged by the PA imaging. In the future, clinically practical organic dyes ͑such as indocyanine green͒ encapsulated in MBs and NBs can be tested in PA imaging. 16 By treating the surface of the bubbles to target specific molecules, the applications of these contrast agents using simultaneous PA and US imaging can be broadened to include not only intracranial tumor boundary mapping but also molecular imaging of primary and metastatic tumor. 
